Abstract

BackgroundParticipating in clinical trials is a metric of high-quality cancer care and improves survival. However, Black individuals with cancer are less likely to be enrolled in clinical trials and experience a disproportionate burden of cancer mortality compared to Whites. Patient-engaged research is one potential strategy to address racial inequities in clinical trials, but little is known about best practices for engaging Black individuals and communities impacted by cancer in research partnerships.MethodsWe used a community engaged research approach to establish a patient advisory council (PAC) representative of the patient population served by a safety net hospital cancer center. We outline the process of establishing the PAC and the lessons learned.ResultsThe inaugural PAC included 7 members representative of the cancer center’s patient demographics. PAC members developed a patient centered vision, mission and action plan. PAC and community-academic research partners experienced the transformative power of centering the lived experiences of patients of color to promote health equity in cancer research.ConclusionEstablishing a patient advisory council at a safety net hospital cancer care center provided a platform for engaging a hardly reached population in patient centered research.

Highlights

  • Participating in clinical trials is a metric of high-quality cancer care and improves survival

  • Racial inequities in the opportunity to participate in clinical trials arise from systemic and interpersonal racism exhibited by the mistreatment and exploitation of Black individuals in clinical research and medical care, negative stereotypes and bias against Black patients, and poor provider communication in racially discordant dyads [7,8,9,10,11,12]

  • We developed flyers that outlined the main goals of the patient advisory council (PAC) which were to increase patient voice in cancer research and develop a strategic plan for patient-powered cancer research

Read more

Summary

Introduction

Participating in clinical trials is a metric of high-quality cancer care and improves survival. Black individuals with cancer are less likely to be enrolled in clinical trials and experience a disproportionate burden of cancer mortality compared to Whites. Patient-engaged research is one potential strategy to address racial inequities in clinical trials, but little is known about best practices for engaging Black individuals and communities impacted by cancer in research partnerships. One potential strategy to address racial inequities in clinical trials is to engage Black patients, caregivers, and community members as research partners [13,14,15,16]. PACs have been shown to be successful in improving participant recruitment and retention in clinical research [20], but a key challenge is engaging diverse members reflective of a health system’s population [24,25,26]. Called “hard to reach” populations, for example patients of color, are typically underrepresented in PACs [25, 27,28,29]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call